Atlas Trials

Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients

Clinical trial NCT07505160 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07505160
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia (AML)
Start date
2026-03-01
Primary completion
2028-03-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.